Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

Share Price is delayed by 15 minutes
Get Live Data
585.00    0.00 (0.00%)
Bid:
580.00
Ask:
590.00
Spread: 10.00 (1.724%)
Market Cap: £238.99m
SAG Live PriceLast checked at - London Stock Exchange

Intraday Science Group Share Chart

Form 8 (OPD) (TP Group plc)

10 Nov 2022 07:00

RNS Number : 8827F
TP Group PLC
10 November 2022
Β 

FORM 8 (OPD)

Β 

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

TP Group plc

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

TP Group plc

(d) Is the discloser the offeror or the offeree?

OFFEREE

(e) Date position held:

The latest practicable date prior to the disclosure

9 November 2022

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Β 

N/A

Β 

2. POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Β 

Class of relevant security:

Β 

Ordinary shares of 1p each in the capital of TP Group plc

Β 

Β 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

Nil

Β 

Nil

Β 

(2) Cash-settled derivatives:

Β 

Nil

Β 

Nil

Β 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

Nil

Β 

Nil

Β 

Β 

TOTAL:

Nil

Β 

Nil

Β 

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

(b) Rights to subscribe for new securities

Β 

Class of relevant security in relation to which subscription right exists:

Nil

Details, including nature of the rights concerned and relevant percentages:

N/A

Β 

Β 

3. POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Β 

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

Β 

a) Ordinary Shares of 1p each in the capital of TP Group plc held by Directors of TP Group plc and their close relatives:

Β 

Name

No. of Shares

% of Issued Share Capital

David Lindsay (Non-Executive Director)

2,600,000

0.33%

Derren Stroud (Chief Financial Officer)

653,847

0.08%

Β 

Β 

b) Options and awards granted under TP Group's share option scheme held by the directors of TP Group plc.

Β 

No directors of TP Group plc hold any options over ordinary shares in TP Group plc, nor any other rights to subscribe for new ordinary shares.

Β 

c) Interests or rights to subscribe held by connected advisers of TP Group plc

Β 

Cenkos Securities plc holds warrants to subscribe for new ordinary shares in TP Group plc:

Β 

Name

Β 

Warrant holder

Description of warrants

Number of warrants over new ordinary shares

Grant date

Lapse date

Exercise price

Cenkos Securities plc

Warrants to subscribe for new ordinary shares in TP Group plc

23,375,361

29 September 2021

29 September 2026

5.8p per share

Β 

Β 

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Β 

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Are any Supplemental Forms attached?

Β 

Supplemental Form 8 (Open Positions)

NO

Supplemental Form 8 (SBL)

NO

Β 

Β 

Date of disclosure:

10 November 2022

Contact name:

Derren Stroud, Chief Financial Officer and Company Secretary

Β 

Telephone number:

Tel: 01753 285802

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
FEEEAKFNEFXAFFA
Date   Source Headline
11th Jan 20217:00 amRNSTrading, Business and Board Update
8th Jan 20214:40 pmRNSTR1: Notification of Major Interest in Shares
2nd Dec 20207:00 amRNSTotal Voting Rights
26th Nov 20207:00 amRNSTransaction in Own Shares
23rd Nov 20207:00 amRNSTransaction in Own Shares
20th Nov 20207:00 amRNSTransaction in Own Shares
18th Nov 20205:00 pmRNSTR1: Notification of Major Interest in Shares
16th Nov 202010:46 amRNSTransaction in Own Shares
16th Nov 202010:45 amRNSTransaction in Own Shares
16th Nov 20207:00 amRNSTransaction in Own Shares
13th Nov 20207:00 amRNSTransaction in Own Shares
11th Nov 20207:00 amRNSPDMR dealing
12th Oct 20207:00 amRNSTrading Update
8th Oct 20207:00 amRNSIssue of share options & PDMR dealing
5th Oct 20207:00 amRNSTR1: Notification of Major Interest in Shares
1st Oct 202011:15 amRNSTR1: Notification of Major Interest in Shares
30th Sep 20202:30 pmRNSDirector Dealing & Exercise of Share Options
30th Sep 20201:30 pmRNSProposed Director Dealing
10th Sep 20207:00 amRNSTrading and Dividend Update
28th Jul 20207:00 amRNSInterim Results for six month period ended 30/6/20
17th Jun 20207:01 amRNSBoard Appointment
17th Jun 20207:00 amRNSNominated Adviser and Joint Broker
16th Jun 202012:15 pmRNSResult of Annual General Meeting
16th Jun 20207:00 amRNSAGM Trading Update
9th Jun 20207:01 amRNSTR1: Notification of Major Interest in Shares
9th Jun 20207:00 amRNSTransaction in Own Shares
8th Jun 20207:00 amRNSTransaction in Own Shares
5th Jun 20207:00 amRNSTransaction in Own Shares
4th Jun 20207:00 amRNSTransaction in Own Shares
29th May 20207:00 amRNSTop Up of Bank Loan
22nd May 20207:00 amRNSTransaction in Own Shares
18th May 20207:00 amRNSTransaction in Own Shares
15th May 20207:00 amRNSPosting of AGM documents and Director Changes
11th May 20207:00 amRNSAGM Update, Capital Allocation and Dividend Policy
7th May 20204:50 pmRNSChange of auditors
7th May 20207:00 amRNSTransaction in Own Shares
6th May 20207:00 amRNSTransaction in Own Shares
4th May 20207:00 amRNSVentilator Programme, Trading & Financial Update
2nd Apr 20204:00 pmRNSTR1: Notification of Major Interest in Shares
2nd Apr 20201:30 pmRNSTR1: Notification of Major Interest in Shares
31st Mar 20201:46 pmRNSTrading Update, AGM and Covid-19
31st Mar 20201:45 pmRNSUK Government Ventilator Programme
20th Mar 20207:00 amRNSTransaction in Own Shares
19th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSAudited results for year ended 31 December 2019
6th Jan 20207:00 amRNSAppointment of Joint Broker
29th Nov 20197:00 amRNSTreasury shares issued
27th Nov 20197:00 amRNSTransaction in Own Shares
26th Nov 20197:00 amRNSTransaction in Own Shares
4th Nov 20197:00 amRNSTreasury shares issues

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.